Nucor to Build Steel Smelter in Australia

Nucor are looking to establish a commercial scale iron ore processing plant at Kwinana, Western Australia. Other joint venture partners in the project include Rio Tinto Group (60%), Mitsubishi Corp (10%) and Shougang Corp (a Chinese Steelmaker, 5%).

The plant which is to be constructed on Rio Tinto’s site at Kwinana will utilise “Hismelt” technology. This involves the injection of non-coking coal and iron ore into a molten bath of iron to convert iron ore to liquid metal. It’s advantage over other technologies is that it creates less environmental impact as it does not require coking ovens and sinter/pellet plants. It can also process iron ores that are deemed not suitable for other steel making processes.

The plant when complete will have capacity to produce 800,000 tons of pig iron (iron content 96%) per year. The location offers excellent access to sea and rail transportation systems.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.